Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma

被引：0
作者：
Wen-Kai Xia
Zhi-Li Liu
Dong Shen
Qing-Feng Lin
Jun Su
Wei-Dong Mao
机构：
[1] The Affiliated Jiangyin Hospital of Southeast University Medical College,Department of Nephrology
[2] The Affiliated Jiangyin Hospital of Southeast University Medical College,Department of Oncology
来源：
World Journal of Surgical Oncology | / 14卷
关键词：
Osteosarcoma; NLR; PLR; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma
    Sato, Yasuyoshi
    Nakano, Kenji
    Wang, Xiaofei
    Fukuda, Naoki
    Urasaki, Tetsuya
    Ohmoto, Akihiro
    Hayashi, Naomi
    Yunokawa, Mayu
    Ono, Makiko
    Tomomatsu, Junichi
    Saito, Masanori
    Minami, Yusuke
    Hayakawa, Keiko
    Funauchi, Yuki
    Tanizawa, Taisuke
    Ae, Keisuke
    Matsumoto, Seiichi
    Takahashi, Shunji
    CANCERS, 2021, 13 (24)
  • [22] Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer
    Berardi, Rossana
    Santoni, Matteo
    Rinaldi, Silvia
    Bower, Marc
    Tiberi, Michela
    Morgese, Francesca
    Caramanti, Miriam
    Savini, Agnese
    Ferrini, Consuelo
    Torniai, Mariangela
    Fiordoliva, Ilaria
    Newsom-Davis, Thomas
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (20)
  • [23] Prognostic value of nomogram based on pre-treatment inflammatory markers in patients with pulmonary-only synchronous metastases from colorectal cancer
    Chen, Linyan
    Li, Qingfang
    Wang, Yexiao
    Yang, Jing
    Ma, Xuelei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77
  • [24] Pre-treatment circulating neutrophil count is an independent prognostic factor in oropharyngeal cancer
    Li, Liang
    Liu, Guangping
    Lu, Honglue
    Jin, Kai
    Zhai, Xiang
    Zhou, Mengqian
    Duan, Yuansheng
    Yue, Kai
    Wu, Yansheng
    Wang, Xudong
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (18)
  • [25] Pre-treatment platelet counts as a prognostic and predictive factor in stage Ⅱ and Ⅲ rectal adenocarcinoma
    Morgan Steele
    Ioannis A Voutsadakis
    World Journal of Gastrointestinal Oncology, 2017, 9 (01) : 42 - 49
  • [26] Prognostic role of pre-treatment serum albumin in patients with nasopharyngeal carcinoma: A meta-analysis and systematic review
    Yang, Huifen
    Wang, Kai
    Liang, Zheng
    Guo, Sitong
    Zhang, Peng
    Xu, Yi
    Zhou, Huifang
    CLINICAL OTOLARYNGOLOGY, 2020, 45 (02) : 167 - 176
  • [27] The prognostic implication of pre-treatment hemoglobin levels in esophageal cancer patients: A systematic review and meta-analysis
    Ran, Zihan
    Chen, Wenjie
    Shang, Jun
    Li, Xuemei
    META GENE, 2020, 25
  • [28] Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer
    Zhang, Yue-Hua
    Lu, Yuquan
    Lu, Hong
    Zhang, Meng-Wei
    Zhou, Yue-Min
    Li, Xiang-Lei
    Lv, Pin
    Zhao, Xiao-Yan
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (01) : 44 - 49
  • [29] Prognostic Role of Pre-Treatment [18F]FDG PET/CT in Patients with Anaplastic Thyroid Cancer
    Kim, Hyun Jeong
    Chang, Hang-Seok
    Ryu, Young Hoon
    CANCERS, 2021, 13 (16)
  • [30] D-D and PLR, NLR combined forecasting first-line treatment: The short-term curative effect and prognosis of patients with SCLC
    Hu, Hui
    Chen, Wen-Jun
    Sun, Chuang
    Xie, Jun-Ping
    MEDICINE, 2023, 102 (45) : E34877
12345